ÜbersichtsarbeitOpen Access
Advanced therapy in familial hypercholesterolemia
Canadian Family Physician · 2026
DOI: 10.46747/cfp.7202106 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Canadian Family Physician, 2026. Verfasst von Edward Gao und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Hyperlipoproteinemia Type II, Anticholesteremic Agents. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Hyperlipoproteinemia Type IIAnticholesteremic AgentsHumansCholesterol, LDLChildAntibodies, Monoclonal, HumanizedPCSK9 InhibitorsHydroxymethylglutaryl-CoA Reductase InhibitorsAntibodies, MonoclonalAngiopoietin-Like Protein 3EzetimibeProprotein Convertase 9
Substanzen
Anticholesteremic AgentsCholesterol, LDLevolocumabAntibodies, Monoclonal, HumanizedPCSK9 InhibitorsHydroxymethylglutaryl-CoA Reductase InhibitorsAntibodies, MonoclonalPCSK9 protein, humanAngiopoietin-Like Protein 3ANGPTL3 protein, human
Zitieren
APA
Gao, E., Brunham, L. R., & Goldman, R. D. (2026). Advanced therapy in familial hypercholesterolemia. Canadian Family Physician. https://doi.org/10.46747/cfp.7202106
Vancouver
Gao E, Brunham LR, Goldman RD. Advanced therapy in familial hypercholesterolemia. Canadian Family Physician. 2026. doi:10.46747/cfp.7202106
BibTeX
@article{Gao2026,
author = {Gao, Edward and Brunham, Liam R and Goldman, Ran D},
title = {Advanced therapy in familial hypercholesterolemia},
journal = {Canadian Family Physician},
year = {2026},
doi = {10.46747/cfp.7202106}
}
EUVIMED